O julgamento ENCIRCLE (ENCIRCLE)
Sistema SAPIEN M3 Substituição da Valva Mitral Transcateter Via Acesso Transeptal
This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable.
Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
This is a prospective single-arm, multicenter study.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Camperdown, Austrália, NSW2050
- Royal Prince Alfred Hospital
-
-
Queensland
-
Chermside, Queensland, Austrália, 4032
- The Prince Charles Hospital
-
-
-
-
-
Toronto, Canadá, M5B 1W8
- St. Michael's
-
Vancouver, Canadá, V6E 1M7
- St. Pauls
-
-
Quebec
-
Québec, Quebec, Canadá, G1V 0A6
- Laval University
-
-
-
-
Alabama
-
Huntsville, Alabama, Estados Unidos, 35801
- Heart Center Hospital
-
-
Arizona
-
Phoenix, Arizona, Estados Unidos, 85006
- Banner University Medical Center
-
Phoenix, Arizona, Estados Unidos, 85013
- Saint Josephs Hospital Medical Center Dignity Health
-
-
California
-
La Jolla, California, Estados Unidos, 92037
- Scripps Health
-
Los Angeles, California, Estados Unidos, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Estados Unidos, 90017
- Good Samaritan Hospital
-
Los Angeles, California, Estados Unidos, 90071
- Kaiser Sunset LA
-
San Francisco, California, Estados Unidos, 94109
- California Pacific Medical Center
-
-
Colorado
-
Loveland, Colorado, Estados Unidos, 80538
- UC Health Northern Colorado (Medical Center of the Rockies)
-
-
Florida
-
Gainesville, Florida, Estados Unidos, 32605
- Cardiac & Vascular Institute Foundation
-
Jacksonville, Florida, Estados Unidos, 32204
- Ascension St. Vincent's Hospital
-
Naples, Florida, Estados Unidos, 34102
- Naples Community Hospital
-
Sarasota, Florida, Estados Unidos, 34239
- Sarasota Memorial Hospital
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30308
- Emory University
-
Atlanta, Georgia, Estados Unidos, 30309
- Piedmont Healthcare
-
-
Illinois
-
Glenview, Illinois, Estados Unidos, 60026
- Northshore University Health System
-
-
Kansas
-
Kansas City, Kansas, Estados Unidos, 66160
- University of Kansas
-
Wichita, Kansas, Estados Unidos, 67226
- Cardiovascular Research Institute of Kansas (CRIOK)
-
-
Louisiana
-
Baton Rouge, Louisiana, Estados Unidos, 70808
- Our Lady of the Lake Regional Medical Center
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21218
- Medstar Union Memorial Hospital
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02114
- Massachusetts General Hospital
-
-
Michigan
-
Detroit, Michigan, Estados Unidos, 48202
- Henry Ford
-
-
Minnesota
-
Rochester, Minnesota, Estados Unidos, 55905
- Mayo Clinic
-
Saint Cloud, Minnesota, Estados Unidos, 56303
- CentraCare
-
-
Missouri
-
Kansas City, Missouri, Estados Unidos, 64111
- Saint Luke's Kansas City
-
-
New Hampshire
-
Lebanon, New Hampshire, Estados Unidos, 03756
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
New Brunswick, New Jersey, Estados Unidos, 08901
- Robert Wood Johnson University Hospital
-
-
New York
-
Buffalo, New York, Estados Unidos, 14203
- University of Buffalo
-
New York, New York, Estados Unidos, 10007
- Weill Cornell Medicine
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28204
- Novant Health and Vascular Institute
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45219
- The Christ Hospital
-
Cleveland, Ohio, Estados Unidos, 44122
- Cleveland Clinic Foundation
-
Columbus, Ohio, Estados Unidos, 43123
- Mount Carmel East Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73120
- Oklahoma Heart Hospital
-
Tulsa, Oklahoma, Estados Unidos, 74104
- Oklahoma Heart Institute
-
-
Pennsylvania
-
Mechanicsburg, Pennsylvania, Estados Unidos, 17050
- UPMC Heart and Vascular Institute
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37205
- Saint Thomas Health
-
-
Texas
-
Austin, Texas, Estados Unidos, 78705
- Austin Heart
-
Houston, Texas, Estados Unidos, 77030
- UT Memorial Hermann
-
Houston, Texas, Estados Unidos, 77004
- HCA Houston Healthcare Medical (SCRI)
-
-
Utah
-
Murray, Utah, Estados Unidos, 84107
- Intermountain Medical Center
-
-
Virginia
-
Norfolk, Virginia, Estados Unidos, 23507
- Sentara Norfolk
-
Roanoke, Virginia, Estados Unidos, 24014
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98195
- University of Washington Seattle
-
-
-
-
-
Leiden, Holanda, 2333 ZA
- Leiden University Medical Center
-
Rotterdam, Holanda, 3015 CE
- Rotterdam Erasmus MC
-
-
-
-
-
Petah Tikva, Israel, 4941492
- Rabin Medical Center
-
-
-
-
-
London, Reino Unido, EC1A 7BE
- Saint Bartholomew's Medical Center
-
London, Reino Unido, SE1 7EH
- Saint Thomas Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- 18 years of age or older
- MR ≥ 3+
- NYHA functional class ≥ II
- Per the Heart Team, commercially available surgical or transcatheter treatment options are deemed unsuitable due to clinical, anatomic or technical considerations.
- Subject's heart failure management has been optimized based on subject characteristics and applicable guidelines, and stable for at least 30 days prior to enrollment.
- The subject or subject's legal representative has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
Exclusion Criteria:
- Mitral/cardiac anatomy that would preclude appropriate delivery and deployment of the SAPIEN M3 dock or valve
- Inappropriate anatomy for femoral introduction and delivery of the SAPIEN M3 dock and valve
- Presence of any device that will contact or interfere with the SAPIEN M3 System during delivery or after implantation
- Left ventricular ejection fraction <25%
- Severe right ventricular dysfunction
- Need for aortic, tricuspid or pulmonic valve intervention within the next 12 months
- History of heart transplant
- Cardiac imaging evidence of intracardiac mass, thrombus or vegetation
- Active bacterial endocarditis within 180 days of the procedure
- Hemodynamic instability requiring inotropic or mechanical support within 30 days of the procedure
- Myocardial infarction within 30 days of the procedure
- Clinically significant untreated coronary artery disease requiring revascularization
- Any percutaneous cardiovascular intervention, cardiovascular surgery, or carotid surgery within 30 days of the procedure
- Stroke or transient ischemic attack within 90 days of the procedure
- Irreversible, severe pulmonary hypertension
- Chronic obstructive pulmonary disease requiring home oxygen therapy or chronic outpatient oral steroid use
- Renal insufficiency or receiving renal replacement therapy
- Liver disease
- Planned surgery within the next 12 months
- Inability to tolerate or a medical condition precluding treatment with antithrombotic therapy, including heparin administration during the procedure
- Active infection requiring current antibiotic therapy
- Active SARS-CoV-2 infection (Coronavirus-19 [COVID-19]) or previously diagnosed with COVID-19 with sequelae that could confound endpoint assessments
- Leukopenia, anemia, thrombocytopenia, history of bleeding diathesis or coagulopathy or hypercoagulable states
- Refusal of blood products
- Female who is pregnant or lactating
- Estimated life expectancy <12 months due to non-cardiac conditions
- Participating in another investigational drug or device study that has not reached its primary endpoint
- Subject considered to be part of a vulnerable population
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: TMVR - Main Cohort
Subjects for whom commercially available surgical or transcatheter treatment options are deemed unsuitable will have transcatheter mitral valve replacement (TMVR). |
During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach. |
|
Experimental: TMVR - Failed TEER Registry
Subjects who have had an attempted but failed transcatheter edge-to-edge repair (TEER) procedure will have TMVR. |
During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach. |
|
Experimental: TMVR - MAC Registry
Subjects with mitral annular calcification (MAC) will have TMVR. |
During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Non-hierarchical composite of death and heart failure rehospitalization
Prazo: 1 year
|
Number of subjects with death and/or heart failure rehospitalization |
1 year
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Improvement in NYHA functional class compared to baseline
Prazo: 1 year
|
New York Heart Association (NYHA) functional classification of heart failure is based on how much a patient is limited during physical activity. The rating ranges from I-IV. I = no limitations of physical activity; II = slight limitations of physical activity, ordinary physical activity results in fatigue, palpitation, shortness of breath; III = marked limitations of physical activity, less than ordinary activity causes fatigue, palpitation, or shortness of breath; IV = unable to carry on any physical activity without discomfort, symptoms of heart failure at rest. |
1 year
|
|
Improvement in KCCQ Overall Score compared to baseline
Prazo: 1 year
|
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. An overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. Scores are transformed to a range of 0-100, in which higher scores reflect better health status. |
1 year
|
|
Improvement in MR compared to baseline
Prazo: 1 year
|
Number of subjects with improved MR compared to baseline |
1 year
|
|
Decrease in LVEDVi compared to baseline
Prazo: 1 year
|
Number of subjects with decreased left ventricular end-diastolic volume index (LVEDVi) compared to baseline |
1 year
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: John Webb, MD, St. Paul's Hospital
- Investigador principal: Mayra Guerrero, MD, Mayo Clinic
- Investigador principal: David Daniels, MD, California Pacific Medical Center
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2018-19
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .